Atlas Trials

Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis

Clinical trial NCT03837743 · COMPLETED

Trial details

NCT number
NCT03837743
Sponsor
Durect
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Plaque Psoriasis
Start date
2019-02-21
Primary completion
2019-11-11
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.